Denmark
Page 7 of 13
RetailInflation has battered the toy market—but defiant Lego saw sales climb 4% in 2023: ‘We continue to grow’
By Prarthana PrakashMarch 12, 2024
LifestyleNovo Nordisk eclipses Tesla on positive trial results for a weight loss drug that may be more powerful than its own Wegovy
By Prarthana PrakashMarch 8, 2024
RetailNovo Nordisk’s Wegovy and Ozempic boom saved Denmark’s GDP from a no-growth 2023—and will help double its expected growth this year, country’s largest bank says
By Niclas Rolander and BloombergMarch 5, 2024
LifestyleNovo Nordisk faces competition close to home as Danish rival Zealand Pharma’s shares jump 35% on ‘groundbreaking’ weight-loss drug trial results
By Prarthana PrakashFebruary 27, 2024
NewslettersDenmark, home to Ozempic-maker Novo Nordisk, is now Europe’s third-most prosperous economy
By Peter Vanham and Nicholas GordonFebruary 27, 2024
FinanceDanish wind giant’s abysmal 3 months have a lot to do with America, ‘the most painful’ part of its portfolio
By Prarthana PrakashFebruary 7, 2024
RetailNovo Nordisk CEO says he was ‘surprised’ to see the popularity of weight-loss drugs in Europe—and people’s readiness to pay out of pocket for them
By Prarthana PrakashFebruary 5, 2024
By Sanne Wass and BloombergJanuary 22, 2024
LifestyleDenmark’s monarchy shake-up takes a fresh twist as King Frederik X publishes a surprise book 3 days after taking the throne
By Prarthana PrakashJanuary 18, 2024
EnvironmentOffshore wind farms are sending electricity to America’s grid for the first time ever—with the help of Europe’s green giants
By Jennifer McDermott and The Associated PressJanuary 4, 2024
RetailShipping giant Maersk’s stock buoyed by halt of Red Sea journeys following Houthi rebel attacks—but it may be bad news for inflation
By Prarthana PrakashJanuary 4, 2024
EnvironmentConservative-backed mission to save the whales collides with lack of evidence that offshore wind is fatal
By Christina Larson, Jennifer McDermott, Patrick Whittle, Wayne Parry and The Associated PressDecember 24, 2023
HealthNovo Nordisk became Europe’s most valuable company with the rise of Wegovy and Ozempic, but it’s facing stiff competition from a local pharma rival
By Christian Wienberg and BloombergDecember 13, 2023
Most Popular
